French startup SparingVision raises $52.6 million
SparingVision, a genomic medicine company focused on ocular diseases, has raised $52.6 million in its first funding round. The round was led by 4BIO Capital, UPMC Enterprises, Jeito Capital, and Ysios Capital with participation from the existing investors Bpifrance and